Chronic Wound Care

Search documents
BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting
Globenewswire· 2025-09-05 16:19
Core Viewpoint - BioStem Technologies, Inc. is showcasing its innovative placental-derived products for chronic wound care at the Symposium for Advanced Wound Care (SAWC) Fall meeting, emphasizing collaboration with Venture Medical, LLC to enhance patient care and streamline treatment processes [1][2]. Company Overview - BioStem Technologies focuses on the development, manufacturing, and commercialization of placental-derived products aimed at advanced wound care [1][11]. - The company utilizes its proprietary BioREtain processing method, which preserves the natural properties of perinatal tissue, ensuring the integrity of amniotic tissue components critical for wound treatment [8][11]. Product Highlights - Key products include AmnioWrap2® and Vendaje AC®, which are exclusively available through Venture Medical [3]. - The BioStem-Venture collaboration aims to provide a superior allograft platform that meets the needs of both patients and healthcare providers [3]. Event Details - The SAWC Fall meeting is taking place from September 3-6 in Las Vegas, NV, serving as a significant educational forum for healthcare professionals focused on chronic wound care [1]. - A sponsored breakfast symposium titled "Navigating the Future of Wound Care" will feature discussions on clinical evidence and best practices in wound care management [4]. Research Contributions - BioStem has three clinical and scientific posters accepted for display at the symposium, contributing to the discourse on chronic wound care [5][10]. - Research topics include comparisons of processing methods for placental tissue allografts and sterilization methods for dehydrated birth tissue [6][10]. Strategic Partnership - The collaboration with Venture Medical enhances the logistics of managing patients requiring skin substitutes for chronic wound treatment, showcasing a combined value proposition [2][3][13].
Dimora PHMB Cleanser Brings Clinical-Grade Wound Care Into Everyday Homes
Globenewswire· 2025-08-29 12:00
Core Insights - Dimora Medical has launched the Dimora PHMB Skin and Wound Cleanser to address the challenges of chronic wound care, particularly for aging populations [1][15] - The cleanser effectively tackles biofilms, which complicate over 78% of chronic wounds, by breaking them down and killing 99.99% of bacteria within minutes [1][4][8] Product Features - The main ingredient, Polyhexamethylene Biguanide (PHMB), has demonstrated the ability to remove 99.49% of biofilm within three minutes and 99.99% after seven minutes [5] - The cleanser provides rapid antimicrobial action, killing 99.99% of bacteria in just two minutes for infected wounds and in one minute for non-infected wounds [8][9] - The product maintains its antimicrobial strength over time, achieving a 99.99% reduction in bacteria even after being opened for 28 days [12] Benefits for Caregivers - The cleanser simplifies the wound care process, allowing caregivers to clean and protect wounds quickly without multiple steps [9][15] - It reduces the risk of infection and complications, providing families with greater confidence in managing chronic wounds at home [6][16] - Dimora Medical aims to make home care easier and less stressful for families, positioning itself as a trusted expert in wound care [15][16]